To identify the c-Met signaling effector responsible for HHLA2-promoted HCC metastasis (metastasis and angiogenesis being the most prominent HHLA2-induced phenotypes), we examined the effect of HHLA2 overexpression in HepG2 cells. This evidence concerns the gene MET and hepatocellular carcinoma.